Biolinerx LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ

14 Aug 2025

BLRX

SCHEDULE: Highbridge Capital Discloses 7.2% Stake in BioLineRx

Highbridge Capital Management, LLC has disclosed a 7.2% beneficial ownership stake in BioLineRx Ltd., primarily through warrants convertible into Ordinary Shares.

NASDAQ

11 Jan 2025

BLRX

Biolinerx LTD

SCHEDULE 13G: Intracoastal Capital Group Discloses 4.99% Passive Stake in BioLineRx Ltd.

A group comprising Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC has disclosed a 4.99% passive beneficial ownership stake in BioLineRx Ltd. as of January 10, 2025, following a recent Securities Purchase Agreement.